Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

From regeneration to immunomodulation: a 20-year global bibliometric analysis of platelet-rich plasma for osteoarthritis

Wang Y., Ren H., Cheng J., Tao H., Feng M.

Clinical Trial on Osteoarthritis, Chronic Inflammation, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Front Med (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41958582
PMCID
PMC13057522
DOI
10.3389/fmed.2026.1790140
Citations
1

Abstract (original English)

Background Osteoarthritis (OA) is a whole-joint disease driven by complex immunopathogenic mechanisms and chronic inflammation, positioning platelet-rich plasma (PRP) as an emerging therapy of significant interest. Objective This study conducts a bibliometric analysis to systematically map the global research landscape, hotspots, and immunological trends of PRP for the treatment of OA from 2004 to 2024. Methods We analyzed 1,862 articles and reviews retrieved from the Web of Science Core Collection (WoSCC) for bibliometric mapping, complemented by 148 clinical trial records from PubMed for qualitative analysis. We utilized VOSviewer, CiteSpace, and the R-package bibliometrix for visual analysis of countries, institutions, authors, journals, and keywords. Results The results demonstrate a significant growth in annual publication volume since 2012, with the United States (1,675 publications) and China (1,310 publications) being the most productive countries. The Rizzoli Orthopaedic Institute, the Hospital for Special Surgery, and Rush University were identified as core research institutions, while Giuseppe Filardo was the most prolific author. The American Journal of Sports Medicine ranked as the leading journal in both publication count and total citations. Keyword analysis identified four major research hotspots: disease targets and tissue mechanisms, pathophysiological process

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research